ID
31324
Beschrijving
Study ID: 104574 Clinical Study ID: AR1104574 Study Title: A randomized blinded pilot trial of fondaparinux sodium (Arixtra®) versus unfractionated heparin in addition to standard therapy in a broad range of patients undergoing percutaneous coronary intervention (ASPIRE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: fondaparinux sodium Trade Name: Arixtra Study Indication: Thromboembolism
Trefwoorden
Versies (1)
- 13-08-18 13-08-18 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
13 augustus 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Fondaparinux sodium (Arixtra) versus unfractionated heparin with patients undergoing PCI; Clinical Study ID: AR1104574
Adverse Event Report
- StudyEvent: ODM
Beschrijving
Adverse event
Alias
- UMLS CUI-1
- C0877248
Beschrijving
Adverse event
Datatype
text
Alias
- UMLS CUI [1]
- C0877248
Beschrijving
Adverse event; Date of onset
Datatype
date
Alias
- UMLS CUI [1]
- C2985916
Beschrijving
Adverse event; start time
Datatype
time
Alias
- UMLS CUI [1]
- C2697889
Beschrijving
Adverse event; maximum intensity
Datatype
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0518690
Beschrijving
Adverse event; Relationship; study drug
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0439849
- UMLS CUI [1,3]
- C0013230
Beschrijving
Adverse event; Relationship; study drug; action taken
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0439849
- UMLS CUI [1,3]
- C0013230
- UMLS CUI [1,4]
- C2826626
Beschrijving
Adverse event; Relationship; study drug; corrective therapies
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0439849
- UMLS CUI [1,3]
- C0013230
- UMLS CUI [1,4]
- C0087111
- UMLS CUI [1,5]
- C0719519
Beschrijving
Adverse event; Outcome
Datatype
text
Alias
- UMLS CUI [1]
- C1705586
Beschrijving
Adverse event; seriousness criteria
Datatype
boolean
Alias
- UMLS CUI [1]
- C1710056
Beschrijving
Adverse event; seriousness; date
Datatype
date
Alias
- UMLS CUI [1,1]
- C1710056
- UMLS CUI [1,2]
- C0808070
Beschrijving
Adverse event; seriousness; time
Datatype
time
Alias
- UMLS CUI [1,1]
- C1710056
- UMLS CUI [1,2]
- C1301880
Beschrijving
Adverse event; seriousness criteria
Datatype
text
Alias
- UMLS CUI [1]
- C1710056
Beschrijving
Adverse event; significan bleeding
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1301880
- UMLS CUI [1,2]
- C0019080
Similar models
Adverse Event Report
- StudyEvent: ODM
C2825181 (UMLS CUI [1,2])
C1300638 (UMLS CUI [1,3])
C2348585 (UMLS CUI [1,2])
C0518690 (UMLS CUI [1,2])
C0439849 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,3])
C0439849 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,3])
C2826626 (UMLS CUI [1,4])
C0439849 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,4])
C0719519 (UMLS CUI [1,5])
C0808070 (UMLS CUI [1,2])
C1301880 (UMLS CUI [1,2])
C0019080 (UMLS CUI [1,2])